Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A -

Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A

Buch | Hardcover
248 Seiten
2021
Academic Press Inc (Verlag)
978-0-323-89939-0 (ISBN)
229,95 inkl. MwSt
Cellular and Molecular Aspects of Myeloproliferative Neoplasms - Part A, Volume 365 in the International Review of Cell and Molecular Biology series reviews and details current advances in cell and molecular biology. Chapters in this new release include MPN a continuum of different disease entities, Bone marrow microenvironment of MPN, Extramedullary hemopoiesis in MPN, The JAK2 mutation, Calreticulin mutations in myeloproliferative neoplasms, and Cytogenetic abnormalities and non-driver mutations in MPN. The IRCMB series has a worldwide readership, maintaining a high standard by publishing invited articles on important and timely topics that are authored by prominent cell and molecular biologists.

The articles published in IRCMB have a high impact and an average cited half-life of 9 years. This great resource ranks high amongst scientific journals dealing with cell biology.

Niccolo Bartalucci practices in Florence, Italy. Dr. Bartalucci is highly rated in 6 conditions, according to our data. His top areas of expertise are Essential Thrombocythemia, Myelofibrosis, Polycythemia Vera, and Splenomegaly. His clinical research consists of co-authoring 34 peer reviewed articles in the past 15 years. Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology. Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.

Preface

Niccolò Bartalucci and Lorenzo Galluzzi

1. Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities

Giacomo Coltro, Giuseppe Gaetano Loscocco and Alessandro M. Vannucchi

2. Bone marrow microenvironment of MPN cells

Alessandro Malara,Christian A. Di Buduo,Vittorio Abbonante and Alessandra Balduini

3. Extramedullary hematopoiesis in myeloproliferative neoplasms: Pathophysiology and treatment strategies

Brian J Chernak and Raajit K Rampal

4. The JAK2 mutation

Salma Merchant

5. The MPL mutation

Paola Guglielmelli and Laura Calabresi

6. Calreticulin mutations in myeloproliferative neoplasms

Kotaro Shide

Erscheinungsdatum
Reihe/Serie International Review of Cell and Molecular Biology
Verlagsort Oxford
Sprache englisch
Maße 152 x 229 mm
Gewicht 520 g
Themenwelt Naturwissenschaften Biologie Genetik / Molekularbiologie
Naturwissenschaften Biologie Zellbiologie
ISBN-10 0-323-89939-0 / 0323899390
ISBN-13 978-0-323-89939-0 / 9780323899390
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
50 Meilensteine der Genetik

von Jonathan Weitzman; Matthew Weitzman

Buch | Hardcover (2022)
Librero b.v. (Verlag)
9,95